These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29499951)

  • 41. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.
    Lozada-Delgado EL; Grafals-Ruiz N; Vivas-Mejía PE
    Life Sci; 2017 Nov; 188():26-36. PubMed ID: 28864225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
    Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
    Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
    Alshamsan A; Hamdy S; Samuel J; El-Kadi AO; Lavasanifar A; Uludağ H
    Biomaterials; 2010 Feb; 31(6):1420-8. PubMed ID: 19913908
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined acetyl-11-keto-β-boswellic acid and radiation treatment inhibited glioblastoma tumor cells.
    Conti S; Vexler A; Edry-Botzer L; Kalich-Philosoph L; Corn BW; Shtraus N; Meir Y; Hagoel L; Shtabsky A; Marmor S; Earon G; Lev-Ari S
    PLoS One; 2018; 13(7):e0198627. PubMed ID: 29969452
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Gonçalves CS; Vieira de Castro J; Pojo M; Martins EP; Queirós S; Chautard E; Taipa R; Pires MM; Pinto AA; Pardal F; Custódia C; Faria CC; Clara C; Reis RM; Sousa N; Costa BM
    Theranostics; 2018; 8(17):4805-4823. PubMed ID: 30279739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. STAT3 silencing with lentivirus inhibits growth and induces apoptosis and differentiation of U251 cells.
    Li GH; Wei H; Chen ZT; Lv SQ; Yin CL; Wang DL
    J Neurooncol; 2009 Jan; 91(2):165-74. PubMed ID: 18839277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
    Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
    Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.
    Kozlowska AK; Florczak A; Smialek M; Dondajewska E; Mackiewicz A; Kortylewski M; Dams-Kozlowska H
    Acta Biomater; 2017 Sep; 59():221-233. PubMed ID: 28694238
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synergistic Targeting HER2 and EGFR with Bivalent Aptamer-siRNA Chimera Efficiently Inhibits HER2-Positive Tumor Growth.
    Xue L; Maihle NJ; Yu X; Tang SC; Liu HY
    Mol Pharm; 2018 Nov; 15(11):4801-4813. PubMed ID: 30222359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting Ephrin Receptor Tyrosine Kinase A2 with a Selective Aptamer for Glioblastoma Stem Cells.
    Affinito A; Quintavalle C; Esposito CL; Roscigno G; Giordano C; Nuzzo S; Ricci-Vitiani L; Scognamiglio I; Minic Z; Pallini R; Berezovski MV; de Francisis V; Condorelli G
    Mol Ther Nucleic Acids; 2020 Jun; 20():176-185. PubMed ID: 32169805
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of Stat3 in glioblastoma multiforme.
    Luwor RB; Stylli SS; Kaye AH
    J Clin Neurosci; 2013 Jul; 20(7):907-11. PubMed ID: 23688441
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The STAT3/Slug Axis Enhances Radiation-Induced Tumor Invasion and Cancer Stem-like Properties in Radioresistant Glioblastoma.
    Lin JC; Tsai JT; Chao TY; Ma HI; Liu WH
    Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30551687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel STAT3 inhibitor, HJC0152, exerts potent antitumor activity in glioblastoma.
    Li Z; Zhu T; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Guo W; Wang Y; Jing C; Dong J; Zhou J; Zhang L; Shen Q; Zhou X
    Am J Cancer Res; 2019; 9(4):699-713. PubMed ID: 31105997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme.
    Chen Y; Liu P; Sun P; Jiang J; Zhu Y; Dong T; Cui Y; Tian Y; An T; Zhang J; Li Z; Yang X
    Theranostics; 2019; 9(5):1453-1473. PubMed ID: 30867843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polyethylenimine-Spherical Nucleic Acid Nanoparticles against Gli1 Reduce the Chemoresistance and Stemness of Glioblastoma Cells.
    Melamed JR; Ioele SA; Hannum AJ; Ullman VM; Day ES
    Mol Pharm; 2018 Nov; 15(11):5135-5145. PubMed ID: 30260647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PEI-Coated Fe₃O₄ Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells.
    Wang R; Degirmenci V; Xin H; Li Y; Wang L; Chen J; Hu X; Zhang D
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30065155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.